Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Dopamine D1 and D2 Receptor Co-activation Generates a Novel Phospholipase C-mediated Calcium Signal*
Samuel P. Lee,
Christopher H. So,
Asim J. Rashid¶||,
George Varghese,
Regina Cheng,
A. José Lança,
Brian F. O'Dowd¶, , and
Susan R. George¶**
Departments of Pharmacology and **Medicine, University of Toronto, Toronto, Ontario M5S 1A8, Canada and the ¶Centre for Addiction and Mental Health, Toronto, Ontario M5T 1R8, Canada
Abstract:
Although dopamine D1 and D2 receptors belong to distinct subfamiliesof dopamine receptors, several lines of evidence indicate thatthey are functionally linked. However, a mechanism for thislinkage has not been elucidated. In this study, we demonstratethat agonist stimulation of co-expressed D1 and D2 receptorsresulted in an increase of intracellular calcium levels viaa signaling pathway not activated by either receptor alone orwhen only one of the co-expressed receptors was activated bya selective agonist. Calcium signaling by D1-D2 receptor co-activationwas abolished following treatment with a phospholipase C inhibitorbut not with pertussis toxin or inhibitors of protein kinaseA or protein kinase C, indicating coupling to the Gq pathway.We also show, by co-immunoprecipitation from rat brain and fromcells co-expressing the receptors, that D1 and D2 receptorsare part of the same heteromeric protein complex and, by immunohistochemistry,that these receptors are co-expressed and co-localized withinneurons of human and rat brain. This demonstration that D1 andD2 receptors have a novel cellular function when co-activatedin the same cell represents a significant step toward elucidatingthe mechanism of the functional link observed between thesetwo receptors in brain.
Received for publication February 22, 2004.
Revision received May 19, 2004.
* This work was supported by grants from the National Instituteon Drug Abuse and from the Canadian Institutes of Health Research.The costs of publication of this article were defrayed in partby the payment of page charges. This article must thereforebe hereby marked "advertisement" in accordance with 18 U.S.C.Section 1734 solely to indicate this fact.
These two authors contributed equally to this work.
|| Supported by a Fellowship from the Centre for Addiction andMental Health.
Holder of a Canada Research Chair in Molecular Neuroscience. To whom correspondence should be addressed: Rm. 4358, Medical Sciences Bldg., 1 King's College Circle, University of Toronto, Toronto, Ontario M5S 1A8, Canada. Tel.: 416-978-3367; Fax: 416-971-2868; E-mail: s.george{at}utoronto.ca.
The editors suggest the following Related Resources on Science sites:
Inhibition of Dopamine Transporter Activity Impairs Synaptic Depression in Rat Prefrontal Cortex Through Over-Stimulation of D1 Receptors.
J. Bai, K. Blot, E. Tzavara, M. Nosten-Bertrand, B. Giros, and S. Otani (2012)
Cereb Cortex
|Abstract »|Full Text »|PDF »
Reversal of quinpirole inhibition of ventral tegmental area neurons is linked to the phosphatidylinositol system and is induced by agonists linked to Gq.
S. Nimitvilai, M. A. McElvain, D. S. Arora, and M. S. Brodie (2012)
J Neurophysiol
108, 263-274
|Abstract »|Full Text »|PDF »
Heterodimerization of serotonin receptors 5-HT1A and 5-HT7 differentially regulates receptor signalling and trafficking.
U. Renner, A. Zeug, A. Woehler, M. Niebert, A. Dityatev, G. Dityateva, N. Gorinski, D. Guseva, D. Abdel-Galil, M. Frohlich, et al. (2012)
J. Cell Sci.
125, 2486-2499
|Abstract »|Full Text »|PDF »
L-DOPA Impairs Proteasome Activity in Parkinsonism through D1 Dopamine Receptor.
A. Berthet, E. Bezard, G. Porras, S. Fasano, P. Barroso-Chinea, B. Dehay, A. Martinez, M.-L. Thiolat, M. Nosten-Bertrand, B. Giros, et al. (2012)
J. Neurosci.
32, 681-691
|Abstract »|Full Text »|PDF »
Occupancy of both sites on the thyrotropin (TSH) receptor dimer is necessary for phosphoinositide signaling.
M. D. Allen, S. Neumann, and M. C. Gershengorn (2011)
FASEB J
25, 3687-3694
|Abstract »|Full Text »|PDF »
Dopamine D2 Receptor Activity Modulates Akt Signaling and Alters GABAergic Neuron Development and Motor Behavior in Zebrafish Larvae.
B. R. Souza, M. A. Romano-Silva, and V. Tropepe (2011)
J. Neurosci.
31, 5512-5525
|Abstract »|Full Text »|PDF »
The Physiology, Signaling, and Pharmacology of Dopamine Receptors.
The Dopamine D1-D2 Receptor Heteromer Localizes in Dynorphin/Enkephalin Neurons: INCREASED HIGH AFFINITY STATE FOLLOWING AMPHETAMINE AND IN SCHIZOPHRENIA.
M. L. Perreault, A. Hasbi, M. Alijaniaram, T. Fan, G. Varghese, P. J. Fletcher, P. Seeman, B. F. O'Dowd, and S. R. George (2010)
J. Biol. Chem.
285, 36625-36634
|Abstract »|Full Text »|PDF »
Formation of {micro}-/{kappa}-opioid receptor heterodimer is sex-dependent and mediates female-specific opioid analgesia.
S. Chakrabarti, N.-J. Liu, and A. R. Gintzler (2010)
PNAS
107, 20115-20119
|Abstract »|Full Text »|PDF »
Dopamine D1-D2 Receptor Heteromer-mediated Calcium Release Is Desensitized by D1 Receptor Occupancy with or without Signal Activation: DUAL FUNCTIONAL REGULATION BY G PROTEIN-COUPLED RECEPTOR KINASE 2.
V. Verma, A. Hasbi, B. F. O'Dowd, and S. R. George (2010)
J. Biol. Chem.
285, 35092-35103
|Abstract »|Full Text »|PDF »
Calcium signaling cascade links dopamine D1-D2 receptor heteromer to striatal BDNF production and neuronal growth.
A. Hasbi, T. Fan, M. Alijaniaram, T. Nguyen, M. L. Perreault, B. F. O'Dowd, and S. R. George (2009)
PNAS
106, 21377-21382
|Abstract »|Full Text »|PDF »
Activation of Glycogen Synthase Kinase-3{beta} Is Required for Hyperdopamine and D2 Receptor-Mediated Inhibition of Synaptic NMDA Receptor Function in the Rat Prefrontal Cortex.
Y.-C. Li, D. Xi, J. Roman, Y.-Q. Huang, and W.-J. Gao (2009)
J. Neurosci.
29, 15551-15563
|Abstract »|Full Text »|PDF »
Background Dopamine Concentration Dependently Facilitates Long-term Potentiation in Rat Prefrontal Cortex through Postsynaptic Activation of Extracellular Signal-Regulated Kinases.
B. Kolomiets, A. Marzo, J. Caboche, P. Vanhoutte, and S. Otani (2009)
Cereb Cortex
19, 2708-2718
|Abstract »|Full Text »|PDF »
Calcium Signaling by Dopamine D5 Receptor and D5-D2 Receptor Hetero-Oligomers Occurs by a Mechanism Distinct from That for Dopamine D1-D2 Receptor Hetero-Oligomers.
C. H. So, V. Verma, M. Alijaniaram, R. Cheng, A. J. Rashid, B. F. O'Dowd, and S. R. George (2009)
Mol. Pharmacol.
75, 843-854
|Abstract »|Full Text »|PDF »
Protein Kinase A Activity Controls the Regulation of T-type CaV3.2 Channels by G{beta}{gamma} Dimers.
C. Hu, S. D. DePuy, J. Yao, W. E. McIntire, and P. Q. Barrett (2009)
J. Biol. Chem.
284, 7465-7473
|Abstract »|Full Text »|PDF »
Heterodimers and Receptor Mosaics of Different Types of G-Protein-Coupled Receptors.
K. Fuxe, D. Marcellino, D. Guidolin, A. S. Woods, and L. F. Agnati (2008)
Physiology
23, 322-332
|Abstract »|Full Text »|PDF »
Identification of Dopamine D1-D3 Receptor Heteromers: INDICATIONS FOR A ROLE OF SYNERGISTIC D1-D3 RECEPTOR INTERACTIONS IN THE STRIATUM.
D. Marcellino, S. Ferre, V. Casado, A. Cortes, B. Le Foll, C. Mazzola, F. Drago, O. Saur, H. Stark, A. Soriano, et al. (2008)
J. Biol. Chem.
283, 26016-26025
|Abstract »|Full Text »|PDF »
Inhibitory effect of D1-like and D3 dopamine receptors on norepinephrine-induced proliferation in vascular smooth muscle cells.
Z. Li, C. Yu, Y. Han, H. Ren, W. Shi, C. Fu, D. He, L. Huang, C. Yang, X. Wang, et al. (2008)
Am J Physiol Heart Circ Physiol
294, H2761-H2768
|Abstract »|Full Text »|PDF »
Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice.
C. Zeng, I. Armando, Y. Luo, G. M. Eisner, R. A. Felder, and P. A. Jose (2008)
Am J Physiol Heart Circ Physiol
294, H551-H569
|Abstract »|Full Text »|PDF »
In vitro functional characteristics of dopamine D2 receptor partial agonists in second and third messenger-based assays of cloned human dopamine D2Long receptor signalling.
S. Jordan, K. Regardie, J. L. Johnson, Ruoyan Chen, J. Kambayashi, R. McQuade, H. Kitagawa, Y. Tadori, and T. Kikuchi (2007)
J Psychopharmacol
21, 620-627
|Abstract »|PDF »
Desensitization of the Dopamine D1 and D2 Receptor Hetero-Oligomer Mediated Calcium Signal by Agonist Occupancy of Either Receptor.
C. H. So, V. Verma, B. F. O'Dowd, and S. R. George (2007)
Mol. Pharmacol.
72, 450-462
|Abstract »|Full Text »|PDF »
Extracellular Signal-Regulated Kinase 1/2-Mediated Transcriptional Regulation of G-Protein-Coupled Receptor Kinase 3 Expression in Neuronal Cells.
S. Salim, K. M. Standifer, and D. C. Eikenburg (2007)
J. Pharmacol. Exp. Ther.
321, 51-59
|Abstract »|Full Text »|PDF »
Dopamine D1/5 Receptor-Mediated Long-Term Potentiation of Intrinsic Excitability in Rat Prefrontal Cortical Neurons: Ca2+-Dependent Intracellular Signaling.
L. Chen, J. D. Bohanick, M. Nishihara, J. K. Seamans, and C. R. Yang (2007)
J Neurophysiol
97, 2448-2464
|Abstract »|Full Text »|PDF »
D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum.
A. J. Rashid, C. H. So, M. M. C. Kong, T. Furtak, M. El-Ghundi, R. Cheng, B. F. O'Dowd, and S. R. George (2007)
PNAS
104, 654-659
|Abstract »|Full Text »|PDF »
Orexin-1 Receptor-Cannabinoid CB1 Receptor Heterodimerization Results in Both Ligand-dependent and -independent Coordinated Alterations of Receptor Localization and Function.
J. Ellis, J. D. Pediani, M. Canals, S. Milasta, and G. Milligan (2006)
J. Biol. Chem.
281, 38812-38824
|Abstract »|Full Text »|PDF »
Serotonin 5-HT2C Receptor Homodimer Biogenesis in the Endoplasmic Reticulum: REAL-TIME VISUALIZATION WITH CONFOCAL FLUORESCENCE RESONANCE ENERGY TRANSFER.
K. Herrick-Davis, B. A. Weaver, E. Grinde, and J. E. Mazurkiewicz (2006)
J. Biol. Chem.
281, 27109-27116
|Abstract »|Full Text »|PDF »
Heterodimers of {alpha}1B- and {alpha}1D-Adrenergic Receptors Form a Single Functional Entity.
C. Hague, S. E. Lee, Z. Chen, S. C. Prinster, R. A. Hall, and K. P. Minneman (2006)
Mol. Pharmacol.
69, 45-55
|Abstract »|Full Text »|PDF »
Inhibition of Serotonin 5-Hydroxytryptamine2C Receptor Function through Heterodimerization: RECEPTOR DIMERS BIND TWO MOLECULES OF LIGAND AND ONE G-PROTEIN.
K. Herrick-Davis, E. Grinde, T. J. Harrigan, and J. E. Mazurkiewicz (2005)
J. Biol. Chem.
280, 40144-40151
|Abstract »|Full Text »|PDF »
From The Cover: Crosstalk in G protein-coupled receptors: Changes at the transmembrane homodimer interface determine activation.
W. Guo, L. Shi, M. Filizola, H. Weinstein, and J. A. Javitch (2005)
PNAS
102, 17495-17500
|Abstract »|Full Text »|PDF »
Aging-Dependent and -Independent Modulation of Associative Learning Behavior by Insulin/Insulin-Like Growth Factor-1 Signal in Caenorhabditis elegans.
H. Murakami, K. Bessinger, J. Hellmann, and S. Murakami (2005)
J. Neurosci.
25, 10894-10904
|Abstract »|Full Text »|PDF »
Dopamine Receptor Oligomerization Visualized in Living Cells.
B. F. O'Dowd, X. Ji, M. Alijaniaram, R. D. Rajaram, M. M. C. Kong, A. Rashid, T. Nguyen, and S. R. George (2005)
J. Biol. Chem.
280, 37225-37235
|Abstract »|Full Text »|PDF »
Heterodimerization of G Protein-Coupled Receptors: Specificity and Functional Significance.
S. C. Prinster, C. Hague, and R. A. Hall (2005)
Pharmacol. Rev.
57, 289-298
|Abstract »|Full Text »|PDF »
D1 and D2 Dopamine Receptors Form Heterooligomers and Cointernalize after Selective Activation of Either Receptor.
C. H. So, G. Varghese, K. J. Curley, M. M. C. Kong, M. Alijaniaram, X. Ji, T. Nguyen, B. F. O'Dowd, and S. R. George (2005)
Mol. Pharmacol.
68, 568-578
|Abstract »|Full Text »|PDF »
The CXCR1 and CXCR2 Receptors Form Constitutive Homo- and Heterodimers Selectively and with Equal Apparent Affinities.
S. Wilson, G. Wilkinson, and G. Milligan (2005)
J. Biol. Chem.
280, 28663-28674
|Abstract »|Full Text »|PDF »
Coactivation of D1 and D2 Dopamine Receptors: In Marriage, a Case of His, Hers, and Theirs.